James M Daly Net Worth & Insider Trades

James M Daly - Director, Halozyme Therapeutics, Inc

As of May 6, 2022

What is James M Daly's Net Worth?

The current estimated net worth of Halozyme Therapeutics, Inc's Director, James M Daly, is estimated to be about $33.17M . James M Daly owns about 21,002 units of Halozyme Therapeutics, Inc common stock. In the last 6 years at Halozyme Therapeutics, Inc, James M Daly has sold an estimated value of $1.42M worth.

What is James M Daly's Past Insider Trading?

James M Daly's largest sale order was 34,337 units , worth over $1M on August 13, 2020. In total, James M Daly has made about 9 transactions over 6 years of their time at Halozyme Therapeutics, Inc. James M Daly usually trades in May, with the busiest year in 2020. The most recent transaction was a sale order of 10,363 units , worth over $418.8K on November 25, 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is James M Daly's' Mailing Address?

  • Mailing address is Incyte Corporation Experimental Station Rte 141 & Henry Clay Rd. Bldg E336 Wilmington DE 19880 DE

Halozyme Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - - - - $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm

What are Halozyme Therapeutics, Inc's Past Insider Trades?

Halozyme Therapeutics, Inc's most recent insider trade came on January 19, 2023 by Helen Torley who sold 30,000 units worth $1.54M . In the last 16 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $140.16M and bought an estimated value of $82.6M worth of shares. Insider trading is most common in May and February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO,  Gregory Ian Frost, CEO,  and Randal J Kirk .

HALOZYME THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1